The Division of Oncology is dedicated to developing multidisciplinary and lifesaving treatments for people worldwide who are affected by cancer. At the forefront of ground breaking treatments for cancer, our faculty is involved in more than 100 clinical trials to develop diagnostic and therapeutic approaches to various types of cancer.
Surgeons turn to basic science in cancer fight
In 2012, a pair of neurosurgery residents traded their scrubs for lab coats in an effort to understand, at the most basic level, what causes medulloblastoma, the most common pediatric brain cancer.
Targeting cancer, sparing healthy cells
Stanford researchers have developed synthetic proteins that can rewire cancer cells in a lab dish by co-opting critical disease-associated pathways.
Taubes give $6 million for cancer research
The gift will advance research on cancer therapies at the School of Medicine and Lucile Packard Children’s Hospital Stanford.
Ovarian cancer mutations undertested
A large study of women with breast and ovarian cancer has revealed significant gaps between national guidelines for genetic testing and actual testing practices, according to researchers from Stanford and five other institutions.
Colon cancer testing at 45 would avert deaths
A Stanford-led study found that increasing the participation of older adults in colorectal cancer screening would help prevent more deaths than expanding testing to people in their 40s.
Conferences and Workshops
New courses are added regularly— please check back often
Non-Stanford CME Courses of Interest
17th Multidisciplinary Management of Cancers: A Case-Based Approach
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.